David Krupa

Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects.

Ian Chapman, Mark A. Bach, Eve Van Cauter et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 260 citations

Aging, Gh Axis, Human Growth +17

Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure¹

Johan Svensson, Lars Lönn, John‐Olov Jansson et al. · The Journal of Clinical Endocrinology & Metabolism · 1998 · 161 citations · Full text

A Randomized, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rofecoxib in the Treatment of Chronic Nonbacterial Prostatitis

J. Curtis Nickel, Michel A. Pontari, Timothy Moon et al. · The Journal of Urology · 2003 · 156 citations

Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585

Gerard J. Hickey, Jennifer E. Drisko, Terry D. Faidley et al. · Journal of Endocrinology · 1996 · 99 citations

Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6.

B. J. Gertz, Jeffrey S. Barrett, Roy Eisenhandler et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 98 citations

Human Growth, Peptide Science, Gastrointestinal Peptide Hormone +17